Sean David

Has grant

Clinical Professor and Vice Chair for Research

University of Chicago

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sean David is a Clinical Professor and Vice Chair for Research at the University of Chicago in the United States. His research focuses on pharmacogenomics, cardiometabolic risk, and the genetic underpinnings of substance use. Recent contributions include studies on the impact of genetic diversity on drug repurposing and the implications of social determinants on healthcare outcomes.

Recent Grants

Grant: Close

Stanford Precision Health for Ethnic and Racial Equity (SPHERE) Transdisciplinary Collaborative Center

Open Date: 2016-04-01

Close Date: 2021-03-01

Grant: Close

Exploratory/Developmental Study of Pharmacogenetic Smoking Cessation Therapy

Open Date: 2009-04-01

Close Date: 2012-03-31

Grant: Close

Extended Treatment for Smoking Cessation

Open Date: 2003-09-15

Close Date: 2015-06-30

Grant: Close

Primary Care Genetics Cancer Prevention Conference

Open Date: 2003-06-01

Close Date: 2004-05-31

Grant: Close

Psychobiological /Genetic Determinants-Smoking Cessation

Open Date: 2002-09-27

Close Date: 2008-05-31

Articles (12)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (23)

LUKE EVANS

University of Colorado Boulder

UNITED STATES

Sean David

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (12)

Two for the heart: Dutch Pharmacogenetic Working Group prescribing guidance on statins and sulfonylureas to reduce cardiometabolic risk

Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing

Powerful, scalable and resource-efficient meta-analysis of rare variant associations in large whole genome sequencing studies

Clonal haematopoiesis and risk of chronic liver disease

The mental health burden of racial and ethnic minorities during the COVID-19 pandemic.

A framework for detecting noncoding rare-variant associations of large-scale whole-genome sequencing studies

Cross-sectional online survey of clinicians’ knowledge, attitudes and challenges to screening and counselling adolescents and young adults for substance use

Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System

Genetic diversity fuels gene discovery for tobacco and alcohol use

Rare genetic variants explain missing heritability in smoking

Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.

The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System

Collaborators (23)

LUKE EVANS

Dajiang Liu

Tinca Polderman

Jessica Lasky-Su

Luisa Zuccolo

Amy Erica Lin

Daniel Weeks

Xihao Li

Gretchen Saunders

Gonneke Willemsen

Tellervo Korhonen

Karin Hoth

Peter Hulick

Tanika Kelly

Nora Franceschini

Allison Ashley-Koch

Mark Graham

James Pirruccello

Albert Vernon Smith

Antonella Mulas

Teemu Palviainen

Henry M Dunnenberger

Sebastien Ourselin

Make your next move.